search
Back to results

Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period (REVOLMUCO)

Primary Purpose

Cystic Fibrosis

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
3 years-assessment of respiratory function
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cystic Fibrosis focused on measuring Time evolution of respiratory function, Longitudinal multicenter monitoring of large cohorts, Preschool aged children, Detection of cystic fibrosis in neonatal period

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient suffering from cystic fibrosis
  • Height between 90 et 130cm
  • No respiratory exacerbation since 4 weeks
  • Benefit from an insurance disease regime

Exclusion Criteria:

  • Law-protected patient
  • Patient's parent don't understand french language
  • Opposition to participation

Sites / Locations

  • University Hospital of Montpellier, Arnaud de Villeneuve

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Preschool aged children detected of CF in neonatal period

Arm Description

Preschool aged children detected of Cystic Fibrosis in neonatal period

Outcomes

Primary Outcome Measures

Time evolution of functional residual capacity by Helium dilution technique (CRF He)

Secondary Outcome Measures

airway resistance by debit interruption technique (Rint)
plethysmographic measure of specific resistance (sRaw)
arterial blood gas measurement
pulmonary clearance index
flow-volume curve
measurement of organ damage
measurement of tobacco exposition
measure of administration antibiotics and antiasthmatics treatments
Comparison of the evolution of these parameters to changing those of a historical cohort evaluated before the introduction of neonatal screening.

Full Information

First Posted
January 21, 2015
Last Updated
April 9, 2020
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT02358798
Brief Title
Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period
Acronym
REVOLMUCO
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
August 19, 2014 (Actual)
Primary Completion Date
January 17, 2020 (Actual)
Study Completion Date
January 17, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The widespread neonatal detection of cystic fibrosis in France since 2002 permits to treat children from birth. New treatments used for young children involve to assess efficacy criteria specific to this population. Standard respiratory function criteria for older children and adults is forced expiratory volume/second. This technique is not suited for preschool aged children (3 to 6 years old) because they are too old to be sedated and too young and immature to be able to make forced expiration technique that are correct, reproducible and prolonged during more than 1 second. For preschool aged children, in order to assess distal damage and her consequence, the evaluations are: airway resistance by debit interruption technic (Rint), plethysmographic measure of specific resistance (sRaw), functional residual capacity by Helium dilution technique (CRF He), arterial blood gas measurement, pulmonary clearance index. All these methods have a better success rate and can be used in alternative or with forced spirometry. However, each of them gives only a part of information on airway and lung damage of detected children. It is necessary to combine them for a better information on overall respiratory damage. In France, each respiratory function test laboratory uses one or any of these methods in addition to flow-volume curve, in function of his practices and his equipment. So, respiratory function test of preschool aged children is going to diversify more and more to the detriment of an homogeneity of practices between different centers. A referent population during a longitudinal multicenter monitoring on large cohorts that describe the evolution of pulmonary function, obtained by a standardized methodology is necessary to assess the efficacy of any new treatment. And, with the homogenization of care of children detected of cystic fibrosis in different centers, the description of natural evolution of pulmonary function by a standardized methodology will improve the discriminative power of measure of respiratory function to assess the presence of a worsening in preschool-aged children.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Time evolution of respiratory function, Longitudinal multicenter monitoring of large cohorts, Preschool aged children, Detection of cystic fibrosis in neonatal period

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Preschool aged children detected of CF in neonatal period
Arm Type
Experimental
Arm Description
Preschool aged children detected of Cystic Fibrosis in neonatal period
Intervention Type
Other
Intervention Name(s)
3 years-assessment of respiratory function
Primary Outcome Measure Information:
Title
Time evolution of functional residual capacity by Helium dilution technique (CRF He)
Time Frame
at each four yearly routine visits
Secondary Outcome Measure Information:
Title
airway resistance by debit interruption technique (Rint)
Time Frame
at each four yearly routine visits
Title
plethysmographic measure of specific resistance (sRaw)
Time Frame
at each four yearly routine visits
Title
arterial blood gas measurement
Time Frame
at each four yearly routine visits
Title
pulmonary clearance index
Time Frame
at each four yearly routine visits
Title
flow-volume curve
Time Frame
at each four yearly routine visits
Title
measurement of organ damage
Time Frame
at each four yearly routine visits
Title
measurement of tobacco exposition
Time Frame
at each four yearly routine visits
Title
measure of administration antibiotics and antiasthmatics treatments
Description
Comparison of the evolution of these parameters to changing those of a historical cohort evaluated before the introduction of neonatal screening.
Time Frame
at each four yearly routine visits

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient suffering from cystic fibrosis Height between 90 et 130cm No respiratory exacerbation since 4 weeks Benefit from an insurance disease regime Exclusion Criteria: Law-protected patient Patient's parent don't understand french language Opposition to participation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
MATECKI SM Stephan, MD
Organizational Affiliation
University Hospital, Montpellier
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Montpellier, Arnaud de Villeneuve
City
Montpellier
ZIP/Postal Code
34295
Country
France

12. IPD Sharing Statement

Learn more about this trial

Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period

We'll reach out to this number within 24 hrs